🇺🇸 FDA
Pipeline program

Cyclophosphamide and Fludarabine

2016-63

Phase 1 small_molecule active

Quick answer

Cyclophosphamide and Fludarabine for Lung Cancer, Nonsmall Cell, Recurrent is a Phase 1 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Lung Cancer, Nonsmall Cell, Recurrent
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials